ChemDiv, Inc.

Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 3,700 highly qualified people. The Company’s 14 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.

MedSource, now part of Ergomed, is an award-winning clinical research organization (CRO) that delivers high-quality clinical trials through strong relationships and specializes in oncology, neurology/CNS, and infectious diseases. We have participated in 795+ clinical trials globally; more than 250 of them have been in oncology. Our efforts support biopharmaceutical clients who conduct complex clinical trials in the most challenging disease states and patient populations. Our wide experience encompasses a range of therapeutic areas, product types, clinical trial phases and study designs.

As trusted advisers and leaders in the industry, we know that strong relationships lead to strong results. While our services have expanded through the years, we’ve always kept our clients, employees and trial subjects a priority. With their needs in mind, we match a flexible process with transparency at every step along the way. Our goal is for our clients to return to MedSource whenever they need high-quality clinical trial support, because they know we will always act with their best interests in mind.

NCGS, Incorporated is a full-service international CRO managing clinical trials since 1984 in drug, biologic, device, diagnostics and consumer products. NCGS provides full-service or strategic sourcing needs focused on risk mitigation. Contingency planning is actively employed, not just planned for. NCGS is a WBENC certified diversity supplier.

NCGS has supported the development or expanded labeling of 78 approved products and has ZERO 483s.
NCGS clinical teams are first in class, highly- tenured professionals
- 10+ years’ experience; A team remains throughout the trial
- Turnover rates are discernibly different at less than 3% annually

CLINICAL TRIAL THERAPEUTIC FOCUS INCLUDES:
- Neuro-Psych (CNS)
- Infectious Diseases / Critical Care
- Oncology, hematology, transplant
- Trials in multiple other areas have been conducted

ROBUST DIVISION OF COMPLIANCE & RECRUITMENT SPECIALIST
- CAPA initiatives
- Due diligence auditing
- eTMF
- Subject recruitment
- Call Center 24/7
- Trial Rescue
- Safety, SAE narratives and SAE reconciliation

FULL SERVICES INCLUDE:
• Clinical Operations and Monitoring
• Fully Integrated e-Based iCloud Systems
- e-REMOTE: Risk-based monitoring
- eTMF: TMF Migration, Consolidation
- ePAY: Grants, Contracts, Payments
- eDM: EDC, IWRS
- ePRO:Patient Reported Outcomes
- eCLIN: CTMS
• Medical Monitoring & Clinical Safety
• Quality Assurance & Regulatory Compliance
• Global Strategic Sourcing
• Medical Writing
• Biostatistics

Parexel is focused on the development of innovative new therapies to improve the world’s health. We do this by providing a suite of groundbreaking biopharmaceutical development services that help customers across the globe transform scientific discoveries into new treatments for patients. From clinical trial design to regulatory and consulting services to commercial and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.

NOTE: Parexel does not contact candidates for employment using Google Hangout, AOL instant Messenger or any other chat service. Please visit Jobs.Parexel.com to review our official online application.

Multispan, Inc. is a premier assay screening technology provider targeting GPCRs, kinases and beyond using endogenously expressed targets in primary cells and recombinant stable cell lines. It has created the industry’s largest, highly characterized, highest quality GPCR-expressing stable cell lines and assays based on cell signaling and phenotypic biology. Multispan offers integrated high quality solutions in assay development, HTS and SAR lead optimization screening support to shorten time to IND and discover better medicine in cardiovascular, metabolic, CNS, inflammation, immunology and oncology diseases. Multispan’s high standard of quality and integrity has earned successful long-term collaborations with a wide range of leading pharmaceutical and biotech companies globally.